Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Artificial Intelligence Gives Rheumatologists an Assist

Mary Beth Nierengarten  |  Issue: June 2021  |  June 14, 2021


Mary Beth Nierengarten is a freelance medical journalist based in Minneapolis.

References

  1. Laghi A. Cautions about radiologic diagnosis of COVID-19 infection driven by artificial intelligence. The Lancet (Digital Health). 2020 May; 2(5):e225.
  2. Engler A. A guide to healthy skepticism of artificial intelligence and coronavirus. Brookings Institute. 2020 Apr 2.
  3. Stoel B. Use of artificial intelligence in imaging in rheumatology—current status and future perspectives. RMD Open. 2020;6:e001063.
  4. Hügle M, Omoumi P, van Laar JM, et al. Rheumatol Adv Pract. 2020;4(1).
  5. Gossec L, Kedra J, Servy H, et al. EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2020 Jan;79(1):69–76.
  6. Pesapane F, Codari M, Sardanelli F. Artificial intelligence in medical imaging: Threat or opportunity? Radiologists again at the forefront of innovation in medicine. Eur Radiol Exp. 2018 Oct 24;2(1):35.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsInformation TechnologyTechnology Tagged with:artificial intelligencebig dataimagingmachine learningTechnology

Related Articles

    Artificial Intelligence in Medicine: The Future Is Now

    August 26, 2020

    Advancements in technology and artificial intelligence designed to aid rheumatologists in diagnosing patients and predicting mortality risk were discussed in depth during a session of the European e-Congress of Rheumatology.

    Bharat Kumar, MD

    Exploring the Role of Artificial Intelligence in Rheumatology

    November 4, 2022

    I looked at the joints. They spoke back to me—”I need more humanism,” they whispered. To longtime readers, those two sentences may sound both familiar and alien, perhaps even a little humorous. That’s because those sentences were generated entirely by a computer using artificial intelligence (AI). It was simple, too: I just copied the text…

    Beyond Trial & Error: RheumMadness 2022 AI: TNFi Response Scouting Report

    February 14, 2022

    As the capabilities of machine learning and artificial intelligence improve, rheumatologists have access to more data than ever, which may enable them to better predict which patients will respond to specific treatments, such as tumor necrosis factor inhibitors.

    How Advances in Artificial Intelligence May Aid Rheumatology

    December 19, 2018

    From digital scribes to predictive pharmacology—as artificial intelligence advances, technology has a lot to offer medicine. What opportunities lie ahead for rheumatologists and their patients?

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences